Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 10,044 shares at $22.80 ($228K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $228k RARE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.54 | 3,119 | $70K | 30.9% |
| 2 | $22.80 | 5,290 | $121K | 53.0% |
| 3 | $22.40 | 1,635 | $37K | 16.1% |
| Total | $22.65 avg | 10,044 | $228K | 100% |
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |